-
Je něco špatně v tomto záznamu ?
Matrix Vaginal Rings for Female Dogs-Effect of Altering Dimensions on Mechanical Properties and Dissolution Characteristics, and In vivo Safety Study
V. Nováková Tkadlečková, V. Pitronová, K. Kubová, S. Pavloková, J. Elbl, R. Novotný, D. Vetchý, J. Vysloužil,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- antikoncepční prostředky ženské * MeSH
- mechanické jevy MeSH
- pevnost v tahu MeSH
- psi MeSH
- rozpustnost MeSH
- testy toxicity MeSH
- uvolňování léčiv MeSH
- zvířata MeSH
- Check Tag
- psi MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The vaginal rings research is almost exclusively focused on rings for human medicine, although the dosage form offers improvement of therapeutic effect in other mammals as well. This contribution studied an effect of varying dimension parameters (diameter 20, 30 or 40 mm; height 3, 4 or 5 mm; width of annulus 5, 7.5 or 10 mm) on mechanical properties and dissolution behaviour of silicone vaginal rings with constant drug amount, intended for use in dogs. Results showed that altering dimensions influenced mechanical properties (compressive force, tensile strength and resistance of removal thread), in vitro drug release and water uptake. The removal thread resistance was increasing with increasing height and width. Compression force was higher for the rings with smaller diameter. The total drug release was increasing with decreasing height and rising diameter, surface area and water uptake during dissolution test. The initial dissolution rate was slower for the rings with higher width. As the best candidate for use in model dog subjects, the ring with 30 mm diameter, 3 mm height and 7.5 mm width was found. These drug-free vaginal rings were further tested in in vivo safety study. The results did not show any major deviation from the physiological conditions. Graphical abstract.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20027942
- 003
- CZ-PrNML
- 005
- 20210114152643.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1208/s12249-020-01770-5 $2 doi
- 035 __
- $a (PubMed)32779033
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Nováková Tkadlečková, Veronika $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, 61242, Brno, Czech Republic.
- 245 10
- $a Matrix Vaginal Rings for Female Dogs-Effect of Altering Dimensions on Mechanical Properties and Dissolution Characteristics, and In vivo Safety Study / $c V. Nováková Tkadlečková, V. Pitronová, K. Kubová, S. Pavloková, J. Elbl, R. Novotný, D. Vetchý, J. Vysloužil,
- 520 9_
- $a The vaginal rings research is almost exclusively focused on rings for human medicine, although the dosage form offers improvement of therapeutic effect in other mammals as well. This contribution studied an effect of varying dimension parameters (diameter 20, 30 or 40 mm; height 3, 4 or 5 mm; width of annulus 5, 7.5 or 10 mm) on mechanical properties and dissolution behaviour of silicone vaginal rings with constant drug amount, intended for use in dogs. Results showed that altering dimensions influenced mechanical properties (compressive force, tensile strength and resistance of removal thread), in vitro drug release and water uptake. The removal thread resistance was increasing with increasing height and width. Compression force was higher for the rings with smaller diameter. The total drug release was increasing with decreasing height and rising diameter, surface area and water uptake during dissolution test. The initial dissolution rate was slower for the rings with higher width. As the best candidate for use in model dog subjects, the ring with 30 mm diameter, 3 mm height and 7.5 mm width was found. These drug-free vaginal rings were further tested in in vivo safety study. The results did not show any major deviation from the physiological conditions. Graphical abstract.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a antikoncepční prostředky ženské $7 D003274
- 650 _2
- $a psi $7 D004285
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mechanické jevy $7 D055595
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a pevnost v tahu $7 D013718
- 650 _2
- $a testy toxicity $7 D018675
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pitronová, Veronika $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, 61242, Brno, Czech Republic.
- 700 1_
- $a Kubová, Kateřina $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, 61242, Brno, Czech Republic.
- 700 1_
- $a Pavloková, Sylvie $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, 61242, Brno, Czech Republic.
- 700 1_
- $a Elbl, Jan $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, 61242, Brno, Czech Republic.
- 700 1_
- $a Novotný, Robert $u Department of Reproduction, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences Brno, Palackého tř. 1946/1, 61242, Brno, Czech Republic.
- 700 1_
- $a Vetchý, David $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, 61242, Brno, Czech Republic.
- 700 1_
- $a Vysloužil, Jakub $u Department of Pharmaceutical Technology, Faculty of Pharmacy, Masaryk University, Palackého tř. 1946/1, 61242, Brno, Czech Republic. jakub.vyslouzil@gmail.com.
- 773 0_
- $w MED00008281 $t AAPS PharmSciTech $x 1530-9932 $g Roč. 21, č. 6 (2020), s. 230
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32779033 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114152641 $b ABA008
- 999 __
- $a ok $b bmc $g 1608277 $s 1119122
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 6 $d 230 $e 20200810 $i 1530-9932 $m AAPS PharmSciTech $n AAPS PharmSciTech $x MED00008281
- LZP __
- $a Pubmed-20210105